Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer

Name: Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer
License: Public Domain

Henan Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 373591
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.